483
Catalent Greenville IncCatalent Greenville Inc – FDA 483, Jul 12, 2019
Record Details
An FDA inspection of Mayne Pharma Inc in Greenville, NC, revealed significant deficiencies in laboratory controls and quality system investigations. The firm failed to establish scientifically sound specifications and test procedures for environmental monitoring and water testing, and did not thoroughly review unexplained discrepancies or out-of-specification/out-of-trend results for drug products.
View Company Profile
ID · bc6cefe3-948d-478e-9077-d2727d1b46a4
Other documents for Catalent Greenville Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.